Effects of medetomidine, L-methadone, and their combination on arterial blood gases in dogs.
To investigate the influence of L-methadone on medetomidine-induced changes in arterial blood gases and clinical sedation in dogs. Prospective experimental cross-over study (Latin square design). Five 1-year-old purpose bred laboratory beagle dogs of both sexes. Each dog was treated three times: medetomidine (20 microg kg(-1) IV), L-methadone (0.1 mg kg(-1) IV) and their combination. Arterial blood was collected for blood gas analysis. Heart and respiratory rates were recorded, and clinical sedation and reaction to a painful stimulus were scored before drug administration and at various time points for 30 minutes thereafter. Arterial partial pressure of oxygen decreased slightly after medetomidine administration and further after medetomidine/L-methadone administration (range 55.2-86.7 mmHg, 7.4-11.6 kPa, at 5 minutes). A slight increase was detected in arterial partial pressure of carbon dioxide after administration of l-methadone and medetomidine/L-methadone (42.6 +/- 2.9 and 44.7 +/- 2.4 mmHg, 5.7 +/- 0.4 and 6.0 +/- 0.3 kPa, 30 minutes after drug administration, respectively). Arterial pH decreased slightly after administration of L-methadone and medetomidine/L-methadone. Heart and respiratory rates decreased after administration of medetomidine and medetomidine/L-methadone, and no differences were detected between the two treatments. Most dogs panted after administration of L-methadone and there was slight sedation. Medetomidine induced moderate or deep sedation, and all dogs were deeply sedated after administration of medetomidine/L-methadone. Reaction to a noxious stimulus was strong or moderate after administration of methadone, moderate or absent after administration of medetomidine, and absent after administration of medetomidine/L-methadone. At the doses used in this study, L-methadone potentiated the sedative and analgesic effects and the decrease in arterial oxygenation induced by medetomidine in dogs, which limits the clinical use of this combination.